Nouveau Visage™ Launches New 5-in-1 Regenerative Microneedling System in the UK

French biomedical aesthetics brand Nouveau Visage™ has announced the UK launch of its regenerative microneedling system, aimed at medical aesthetic clinics and dermatology practices. The UK rollout is being carried out in partnership with Fox Pharma, MedFx, and John Bannon.

The system, developed by Laboratoire Nouveau Visage, incorporates the Regen³ Complex, a patented formulation combining exosomes, PDRN, and biomimetic peptides. The complex is designed to support cellular communication, fibroblast activity, and extracellular matrix renewal.

The Nouveau Visage™ professional range, called NEWDERM™, includes five targeted microneedling protocols:

• NEWDERM™ Age Control – addresses wrinkles, dehydration, and loss of elasticity
• NEWDERM™ Bright – targets melasma, sun damage, and uneven skin tone
• NEWDERM™ Eye – developed for the periorbital area to improve dark circles, under-eye bags, and fine lines
• NEWDERM™ Hair – supports scalp health and hair density
• NEWDERM™ Lift – focuses on skin laxity and dermal structure

Each protocol contains the Regen³ Complex, combining exosomes, PDRN, and biomimetic peptides to support tissue repair, collagen synthesis, and skin structure.

Carlos Royo, Executive Partner & CEO at Nouveau Visage, noted that the UK market is increasingly focused on regenerative treatments and highlighted the company’s plans to work with clinics and industry partners during the rollout.

The UK launch will be formally presented at an education and networking event on 12 May at the Bulgari Hotel, London, bringing together clinical educators, key opinion leaders, and industry partners. The event will include presentations on the science behind Nouveau Visage™ and clinical protocols for integrating regenerative microneedling into existing clinic offerings.

Nouveau Visage™ has already launched in over twenty international markets and operates under ISO and GMP manufacturing standards. Clinics interested in the UK launch event or the Nouveau Visage system can contact Fox Pharma at contact@nouveau-visage.com.